PRDS — Pardes Biosciences Balance Sheet
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- $133.95m
- -$19.25m
Annual balance sheet for Pardes Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 3.41 | 269 | 197 |
| Prepaid Expenses | |||
| Total Current Assets | 3.6 | 275 | 200 |
| Other Long Term Assets | |||
| Total Assets | 3.6 | 275 | 201 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 16.6 | 8.96 | 20.4 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 16.6 | 8.96 | 20.4 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | -13 | 266 | 180 |
| Total Liabilities & Shareholders' Equity | 3.6 | 275 | 201 |
| Total Common Shares Outstanding |